Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, David J, Tan, Gene S, Palese, Peter, Ravetch, Jeffrey V·2014·Nature Medicine
DOI 10.1038/nm.3443

Cited by (763)

Items 501–600 of 763

  1. Contribution of Fc-dependent cell-mediated activity of a vestigial esterase-targeting antibody against H5N6 virus infection
    Zhiqiang Zheng, Catherine Su Hui Teo, Suganya Cheyyatraivendran Arularasu, Zhehao Liu, Nur Khairiah Mohd-Ismail, Chee Keng Mok, Chee Bing Ong, Justin Jang Hann Chu, Yee‐Joo Tan · 2020 · Emerging Microbes & Infections
  2. The Role and Function of Fcγ Receptors on Myeloid Cells
    Stylianos Bournazos, Taia T. Wang, Jeffrey V. Ravetch · 2017 · ASM Press eBooks
  3. Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form
    Jong Hyeon Seok, Jeong‐Won Kim, Dan Bi Lee, Ki Joon Cho, Jihye Lee, Garam Bae, Mi Sook Chung, Kyung Hyun Kim · 2017 · Scientific Reports
  4. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
    Yawei Ni, Jianhua Guo, Debra D. Turner, Ian R. Tizard · 2018 · Frontiers in Immunology
  5. Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5
    Joel Finney, Guang Yang, Masayuki Kuraoka, Shengli Song, Takuya Nojima, Laurent K. Verkoczy, Daisuke Kitamura, Barton F. Haynes, Garnett H. Kelsoe · 2019 · The Journal of Immunology
  6. Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice
    Santosh Dhakal, Sharvari Deshpande, Meagan McMahon, Shirin Strohmeier, Florian Krammer, Sabra L. Klein · 2020 · Vaccine
  7. Influenza prevention and treatment by passive immunization.
    Barbara Kalenik, Róża Sawicka, Anna Góra‐Sochacka, Agnieszka Sirko · 2014 · Acta Biochimica Polonica
  8. Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses
    Arne Matthys, Jan Félix, João Paulo Portela Catani, Kenny Roose, Wim Nerinckx, Benthe Van Buyten, Daria Fijałkowska, Nico Callewaert, Savvas N. Savvides, Xavier Saelens · 2025 · Nature Communications
  9. CD47 inhibits phagocytosis through Vav dephosphorylation
    Wyatt D. Miller, Andrew Manion, Abhinava K. Mishra, Connor J. Sheedy, Annalise Bond, Brooke M. Gardner, Denise J. Montell, Meghan A. Morrissey · 2025 · The Journal of Cell Biology
  10. Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1
    Corey A. Balinsky, Le Jiang, Vihasi Jani, Ying Cheng, Zhiwen Zhang, Tatyana Belinskaya, Qi Qiu, Tran Khanh Long, Megan A. Schilling, Sarah A. Jenkins et al. · 2023 · Frontiers in Immunology
  11. Development of Self-Assembled Protein Nanocage Spatially Functionalized with HA Stalk as a Broadly Cross-Reactive Influenza Vaccine Platform
    Jaeyoung Park, Julie A. Champion · 2023 · ACS Nano
  12. Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin
    Joel Finney, Annie Park Moseman, Susan Kong, Akiko Watanabe, Shengli Song, Richard M. Walsh, Masayuki Kuraoka, Ryutaro Kotaki, E. Ashley Moseman, Kevin R. McCarthy et al. · 2023 · Proceedings of the National Academy of Sciences
  13. Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic
    Annelies W. Mesman, Brenda M. Westerhuis, Hinke I ten Hulscher, Ronald H. J. Jacobi, Erwin de Bruin, Josine van Beek, Anne‐Marie Buisman, Marion Koopmans, Rob S. van Binnendijk · 2016 · Journal of General Virology
  14. Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies
    Juan Manuel Carreño, Jacqueline U. McDonald, Tara Patricia Hurst, Peter Rigsby, Eleanor Atkinson, Lethia Charles, Raffael Nachbagauer, Mohammad Amin Behzadi, Shirin Strohmeier, Lynda Coughlan et al. · 2020 · Vaccines
  15. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection In Vivo
    Haley N. Cartwright, Dominique J. Barbeau, Anita K. McElroy · 2021 · mSphere
  16. Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
    Francisco Fuentes‐Villalobos, José Luis Velasco Garrido, Matías A. Medina, Nicole Zambrano, Natalia Ross, Felipe Bravo, Aracelly Gaete-Argel, Aarón Oyarzún-Arrau, Fatima Amanat, Ricardo Soto‐Rifo et al. · 2022 · Frontiers in Immunology
  17. Engineering the supernatural: monoclonal antibodies for challenging infectious diseases
    Patricia S. Grace, Bronwyn M. Gunn, Lenette L. Lu · 2022 · Current Opinion in Biotechnology
  18. Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it
    Wei Wang, Russell A. Vassell, Hyo Sook Song, Chen Qiong, Paul W. Keller, Swati Verma, Esmeralda Alvarado-Facundo, Hongquan Wan, Falko Schmeisser, Clement A. Meseda et al. · 2019 · PLoS ONE
  19. Different mechanisms of the protection against influenza A infection mediated by broadly reactive HA2-specific antibodies
    Karolína Tomčíková, Eva Varečková · 2019 · Acta Virologica
  20. Poly(methyl methacrylate)-Based Nanofluidic Device for Rapid and Multiplexed Serological Antibody Detection of SARS-CoV-2
    Thomas Mortelmans, Dimitrios Kazazis, Celestino Padeste, Philipp Berger, Xiaodan Li, Yasin Ekinci · 2022 · ACS Applied Nano Materials
  21. Entamoeba histolytica HM-1: IMSS gene expression profiling identifies key hub genes, potential biomarkers, and pathways in Amoebiasis infection: a systematic network meta-analysis
    Ram Nayan Verma, Md. Zubbair Malik, Naidu Subbarao, Gajendra Pratap Singh, Durgesh Nandini Sinha · 2022 · Bioscience Reports
  22. Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection
    Guozhang Zou, Martina Košíková, Su-Ryun Kim, Shweta Kotian, Wells W. Wu, Rong‐Fong Shen, David N. Powers, Cyrus D. Agarabi, Hang Xie, Tongzhong Ju · 2018 · Journal of Biological Chemistry
  23. An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice
    Kota Senpuku, Chikako Kataoka-Nakamura, Yuta Kunishima, Toshiro Hirai, Yasuo Yoshioka · 2024 · Vaccine
  24. Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection
    Anna L. Beukenhorst, Keira Lee Rice, Jacopo Frallicciardi, Martin H. Koldijk, Carolyn M. Boudreau, Justin Crawford, Lisette A. H. M. Cornelissen, Kelly A. S. da Costa, Babette A. de Jong, Stephanie Fischinger et al. · 2025 · Scientific Reports
  25. Influenza vaccines: ‘tailor-made’ or ‘one fits all’
    Giulietta Saletti, Thomas H. Gerlach, Guus F. Rimmelzwaan · 2018 · Current Opinion in Immunology
  26. Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes
    Alec W. Freyn, Julianna Han, Jenna J. Guthmiller, Mark J. Bailey, Karlynn E. Neu, Hannah L. Turner, Victoria C. Rosado, Veronika Chromikova, Min Huang, Shirin Strohmeier et al. · 2021 · Proceedings of the National Academy of Sciences
  27. Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination
    Xuemin Chen, He-Ying Sun, Chun‐Yi Lee, Christina A. Rostad, Jessica F. Trost, Rodrigo B. Abreu, Michael A. Carlock, Jason R. Wilson, Shane Gansebom, Ted M. Ross et al. · 2022 · Virology
  28. Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice
    Martin Beukema, Shuran Gong, Kasem Al-Jaawni, Jacqueline J. de Vries-Idema, Florian Krammer, Fan Zhou, Rebecca Jane Cox, Anke L. W. Huckriede · 2023 · Frontiers in Immunology
  29. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses
    Xun Huang, Qianqian Zhu, Xiaoxing Huang, Lifei Yang, Yufeng Song, Ping Zhu, Paul Zhou · 2017 · Vaccine
  30. Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies
    Shuangshuang Wang, Huanhuan Ren, Wenbo Jiang, Honglin Chen, Hongxing Hu, Zhiwei Chen, Paul Zhou · 2017 · Journal of Virology
  31. Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy
    Brian J. Morrison, Jessica A. Roman, Thomas C Luke, Nishith Nagabhushana, Kanakatte S. Raviprakash, Maya Williams, Peifang Sun · 2017 · Journal of Virological Methods
  32. Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?
    Daniel Stadlbauer, Raffael Nachbagauer, Philip S. Meade, Florian Krammer · 2017 · Frontiers of Medicine
  33. Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
    Andrew Tung Yep, Yasu Takeuchi, Othmar G. Engelhardt, Simon E. Hufton · 2021 · Biomolecules
  34. Retroviruses, immunosuppression and osteopetrosis.
    M.L. Labat · 1986 · PubMed
  35. Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1
    Srivamshi Pittala, Kyle S. Morrison, Margaret E. Ackerman · 2019 · Current Opinion in HIV and AIDS
  36. Circulating multimeric immune complexes drive immunopathology in COVID-19
    Jakob Ankerhold, Sebastian Giese, Philipp Kolb, Andrea Maul-Pavicic, Reinhard Edmund Voll, Nathalie Göppert, Kevin Ciminski, Clemens Kreutz, Achim Lother, Ulrich Salzer et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes
    Shiho Chiba, Huihui Kong, Gabriele Neumann, Yoshihiro Kawaoka · 2023 · mBio
  38. Antigen spatial-matching polyaptamer nanostructure to block coronavirus infection and alleviate inflammation
    Jingqi Chen, Yuqing Li, Xueliang Liu, Hongyi Li, Jiawei Zhu, Rui Ma, Linxin Tian, Lu Yu, Jiabei Li, Zhuang Liu et al. · 2024 · Chem
  39. Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations
    Teha Kim, Lynn H. Bimler, Sydney L. Ronzulli, Amber Y. Song, Scott K. Johnson, Cheryl A. Jones, Stephen Mark Tompkins, Silke Paust · 2025 · Science Advances
  40. Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays
    Alberto Cagigi, Nicola Cotugno, Stefano Rinaldi, Veronica Santilli, Paolo Rossi, Paolo Palma · 2015 · Pediatric Allergy and Immunology
  41. Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
    Svenja Weiß, Vincenza Itri, Ruimin Pan, Xunqing Jiang, Christina C. Luo, Lynn Morris, Delphine C. Malherbe, Philip T. Barnette, Jeff Alexander, Xiang‐Peng Kong et al. · 2022 · Nature Communications
  42. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication
    Wentao Shen, Qian Wang, Zhengxiang Wang, Minxuan Liu, Yingying Du, Lvfeng Yuan, Lu Han, Krzysztof Śmietanka, Hualan Chen, Shuai Xu et al. · 2022 · Journal of Virology
  43. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses
    Michael Storcksdieck genannt Bonsmann, Thomas Niezold, Drew Hannaman, Klaus Überla, Matthias Tenbusch · 2016 · Vaccine
  44. Enrichment of high affinity subclasses and glycoforms from serum‐derived IgG using FcγRs as affinity ligands
    Austin W. Boesch, James H. Kappel, Alison E. Mahan, Thach H. Chu, Andrew R. Crowley, Nana Yaw Osei‐Owusu, Galit Alter, Margaret E. Ackerman · 2018 · Biotechnology and Bioengineering
  45. Toward universal influenza virus vaccines: from natural infection to vaccination strategy
    Chen Zhao, Jianqing Xu · 2018 · Current Opinion in Immunology
  46. Enhancing FcγR-mediated antibody effector function during persistent viral infection
    Andreas Wieland, Alice Oliffson Kamphorst, Rajesh M. Valanparambil, Jin-Hwan Han, Xiaojin Xu, Biswa Choudhury, Rafi Ahmed · 2018 · Science Immunology
  47. Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults
    Hillary A. Vanderven, Ian Barr, Arnold Reynaldi, Adam K. Wheatley, Bruce D. Wines, Miles P. Davenport, Philip Mark Hogarth, Stephen John Kent · 2020 · Vaccine
  48. Immune Evasion by Herpes Simplex Viruses
    Angello R Retamal-Díaz, Eduardo I. Tognarelli, Alexis M. Kalergis, Susan M. Bueno, Pablo A. González · 2016 · InTech eBooks
  49. B Cells and Functional Antibody Responses to Combat Influenza
    Giuseppe Lofano, Arun Kumar, Oretta Finco, Giuseppe Del Giudice, Sylvie Bertholet · 2015 · Frontiers in Immunology
  50. The challenges of a neglected STI: Molluscum contagiosum.
    Leonardo Zichichi, Mario Maniscalco · 2012 · PubMed
  51. Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection
    Hillary A. Vanderven, Kathleen M. Wragg, Fernanda Ana‐Sosa‐Batiz, Anne B. Kristensen, Sinthujan Jegaskanda, Adam K. Wheatley, Deborah N. Wentworth, Bruce D. Wines, Philip Mark Hogarth, Steve Rockman et al. · 2018 · The Journal of Infectious Diseases
  52. An approach to the influenza chimeric subunit vaccine (3M2e-HA2-NP) provides efficient protection against lethal virus challenge
    Maryam Saleh, Jamileh Nowroozi, Behrokh Farahmand, Fatemeh Fotouhi · 2020 · Biotechnology Letters
  53. Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection
    Niloufar Kavian, Asmaa Hachim, Leo L. M. Poon, Sophie A. Valkenburg · 2020 · Vaccine
  54. Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
    Jan M. Sobczak, Irena Barkovska, Ina Baļķe, Dominik A. Rothen, Mona Omar Mohsen, Dace Skrastiņa, Anete Ogrina, B. E. E. Martina, Juris Jansons, Jānis Bogans et al. · 2024 · Vaccines
  55. How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza
    Craig Thompson, Rebecca Steventon, Lucas Stolle · 2025 · Antibodies
  56. Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
    Jerry C H Tam, Abbie C. Sibayan, Jeffrey Seow, Carl Graham, Ashwini Kurshan, Blair Merrick, Richard James Stanton, Katie J. Doores · 2025 · Cell Reports
  57. Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection
    Natalie E. Stevens, Antoinette Hatjopolous, Cara K. Fraser, Mohammed Alsharifi, Kerrilyn R. Diener, John D. Hayball · 2016 · Scientific Reports
  58. Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
    Mallory L. Myers, John R. Gallagher, De’Marcus D. Woolfork, Regan K. Stradtmann-Carvalho, Samantha Maldonado-Puga, Kevin W. Bock, Seyhan Boyoglu-Barnum, Hubza Syeda, Adrian Creanga, Derron A. Alves et al. · 2022 · Frontiers in Immunology
  59. Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice
    Sumin Son, Soo Bin Ahn, Geonyeong Kim, Yejin Jang, Chunkyu Ko, Meehyein Kim, Sang Jick Kim · 2023 · Antiviral Research
  60. Pilot-scale production of inactivated monoglycosylated split H1N1 influenza virus vaccine provides cross-strain protection against influenza viruses
    Chia-Ying Wu, Shao-En Kao, Yung-Chieh Tseng, Yu-Po Lin, Jen-Tzu Hou, Liyang Wu, Sharon Chiu, Che Alex Ma, Pei‐Wen Hsiao, Jane H. Hsiao et al. · 2023 · Antiviral Research
  61. Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
    Javier G. Magadán, Meghan O. Altman, William L. Ince, Heather D. Hickman, James Stevens, Aaron A. Chevalier, David A. Baker, Patrick C. Wilson, Rafi Ahmed, Jack R. Bennink et al. · 2014 · PLoS Pathogens
  62. Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans
    Marija Zaric, Arianna Marini, Carolyn M. Nielsen, Gaurav Gupta, David Mekhaiel, Thao Pham, Sean C. Elias, Iona Jennifer Taylor, Hans de Graaf, Ruth Payne et al. · 2021 · Frontiers in Immunology
  63. Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection
    Anna A. Zykova, Elena A. Blokhina, Liudmila A. Stepanova, Marina A. Shuklina, Olga O. Ozhereleva, Liudmila M. Tsybalova, Victor V. Kuprianov, Nikolai V. Ravin · 2023 · Molecules
  64. [Immune evasion by herpes simplex viruses].
    Angello R Retamal-Díaz, Paula A. Suazo, Ignacio Garrido, Alexis M. Kalergis, Pablo A. González · 2015 · PubMed
  65. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine
    Sarah M. Tete, Åsne Jul‐Larsen, Sina Rostami, Turid Helen Felli Lunde, Hanne Søland, Florian Krammer, Rebecca Jane Cox · 2018 · Vaccine
  66. A broadly neutralizing antibody confers cross-genus protection against alphaherpesviruses by inhibiting gB-mediated membrane fusion
    Guosong Wang, Yu Li, Chongxin Wu, Tian Chen, Mengxuan Gui, Yue Zeng, Hui Sun, Kaiyun Chen, Xiangfeng Xi, Yanbo Yang et al. · 2025 · Nature Communications
  67. Development of a potent monoclonal antibody for treatment of human metapneumovirus infections
    Evelyn D. Harris, Morgan McGovern, Sara Pernikoff, Ren Ikeda, Lea Kipnis, William W. Hannon, Elizabeth B. Sobolik, Matthew D. Gray, Alexander L. Greninger, Sijia He et al. · 2026 · Nature Communications
  68. Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial
    Carolyn M. Boudreau, John Stephen Burke, Kiel D. Shuey, Caitlin R. Wolf, Joanne Katz, James M. Tielsch, Subarna K. Khatry, Steven C. LeClerq, Janet A. Englund, Helen Y. Chu et al. · 2022 · Cell Reports
  69. Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
    Maarten Swart, Harmjan Kuipers, Fin J. Milder, Mandy A. C. Jongeneelen, Tina Ritschel, Jeroen T. B. M. Tolboom, Leacky K. Muchene, Joan E. M. van der Lubbe, Ana Izquierdo Gil, Daniel Veldman et al. · 2023 · npj Vaccines
  70. Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
    Jennifer L. Schwedler, Maxwell A. Stefan, Christine E. Thatcher, Peter R. McIlroy, Anupama Sinha, Ashlee M. Phillips, Christopher A. Sumner, Colleen M. Courtney, Christina Y. Kim, Dina R. Weilhammer et al. · 2024 · mAbs
  71. SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination
    Shishan Teng, Yabin Hu, You Wang, Yinggen Tang, Qian Wu, Xingyu Zheng, Rui Lü, Dong Pan, Fen Liu, Tianyi Xie et al. · 2024 · Frontiers in Immunology
  72. The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections
    Miriam Klausberger, Ирина Анатольевна Ленева, Irina N. Falynskova, Kirill Vasilev, А. В. Поддубиков, Claudia Lindner, Карташова Надежда Павловна, О. А. Свитич, Marina Stukova, Reingard Maria Grabherr et al. · 2019 · Vaccines
  73. Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
    Núria Pedreño-López, Brandon C. Rosen, Walter J. Flores, Matthew J. Gorman, Thomas B. Voigt, Michael J. Ricciardi, Kristin Crosno, Kim L. Weisgrau, Christopher L. Parks, Jeffrey D. Lifson et al. · 2021 · Frontiers in Immunology
  74. Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats
    Chunhong Dong, Bao‐Zhong Wang · 2021 · Advanced NanoBiomed Research
  75. Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice
    Abenaya Muralidharan, Caroline Gravel, Greg Harris, Anwar M. Hashem, Wanyue Zhang, David Safronetz, Gary Van Domselaar, Florian Krammer, Simon Sauvé, Michael Rosu‐Myles et al. · 2022 · Human Vaccines & Immunotherapeutics
  76. Comparative Characterization of Diverse DNA Aptamers for Recognition of Spike Proteins of Multiple SARS‐CoV‐2 Variants
    Zijie Zhang, Jiuxing Li, Ryan Amini, Alexandria Mansfield, Jimmy Gu, Jianrun Xia, John D. Brennan, Yingfu Li · 2023 · Analysis & Sensing
  77. Outsmarting Pathogens with Antibody Engineering
    Ahlam N. Qerqez, Rui P. Silva, Jennifer A. Maynard · 2023 · Annual Review of Chemical and Biomolecular Engineering
  78. Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates
    Susan Zolla‐Pazner · 2016 · AIDS
  79. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk
    Ji‐Rong Yang, Chieh-Yu Cheng, Chih-Yuan Chen, Chaohua Lin, Chuan‐Yi Kuo, Hsiang‐Yi Huang, Fu-Ting Wu, Yu‐Chih Yang, Chia-Ying Wu, Ming‐Tsan Liu et al. · 2017 · Antiviral Research
  80. Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head
    Yulu Wang, Dan Hu, Yanling Wu, Tianlei Ying · 2020 · Frontiers of Medicine
  81. A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface
    Holly C. Simmons, Joel Finney, Ryutaro Kotaki, Yu Adachi, Annie Park Moseman, Akiko Watanabe, Shengli Song, Lindsey R. Robinson‐McCarthy, Valerie Le Sage, Masayuki Kuraoka et al. · 2025 · mBio
  82. Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling
    Karel F. A. Van Damme, Dorine Sichien, Katrien Van der Borght, Justine Van Moorleghem, Sofie Van Gassen, Joseph Jorssen, Seppe De Winter, Elisabeth De Leeuw, Caihong Wang, Qingqing Chai et al. · 2026 · Science Immunology
  83. Different Arms of the Adaptive Immune System Induced by a Combination Vaccine Work in Concert to Provide Enhanced Clearance of Influenza
    Joanna C. A. Cobbin, Weiguang Zeng, David Charles Jackson, Lorena E. Brown · 2014 · PLoS ONE
  84. Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
    Julie M. Fox, Vicky Roy, Bronwyn M. Gunn, Glen Bolton, Daved H. Fremont, Galit Alter, Michael Diamond, Austin W. Boesch · 2023 · Frontiers in Immunology
  85. Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
    Hillary A. Vanderven, Deborah N. Wentworth, Win Min Han, Heidi Peck, Ian Barr, Richard T. Davey, John H. Beigel, Dominic Edmund Dwyer, Mamta K. Jain, Brian Angus et al. · 2023 · JCI Insight
  86. Engineering of novel hemagglutinin biosensors for rapid detection and drug screening of Influenza A H7N9 virus
    Xin Chen, Yuan Huang, Peixuan Gao, Fang Wu, Yongyue Han, Chuwen Zhang, Zhuowen Hu, Fang Zhao, Д. Н. Щербаков, Weiqi Pan et al. · 2023 · International Journal of Biological Macromolecules
  87. Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus
    Dmitry V. Shcheblyakov, Daria V. Voronina, Irina A. Favorskaya, Ilias B. Esmagambetov, I. A. Alekseeva, Anastasia I. Korobkova, Ekaterina I. Ryabova, Artem A. Derkaev, Vladislav Y. Kan, Alina Sh. Dzharullaeva et al. · 2024 · Acta Naturae
  88. Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin
    Gunnveig Grødeland, Marta Baranowska-Hustad, Justin R. Abadejos, Tanya R. Blane, John Ross Teijaro, David A. Nemazee, Bjarne Bogen · 2020 · Frontiers in Immunology
  89. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination
    Melissa M. Lemke, Robert M. Theisen, Emily R. Bozich, Milla R. McLean, Christina Y. Lee, Ester López, Supachai Rerks‐Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Sven Kratochvil et al. · 2022 · Frontiers in Immunology
  90. Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
    Mireia Pelegrín, Soledad Marsile-Medun, Daouda Abba Moussa, Manon Souchard, Mar Naranjo‐Gómez · 2022 · Antibodies
  91. Integrated Whole-Exome and Transcriptome Sequencing Indicated Dysregulation of Cholesterol Metabolism in Eyelid Sebaceous Gland Carcinoma
    Yuchuan Wang, Jun Li, Peng Hao, Jing Li, Ruifang Han, Jinyong Lin, Xuan Li · 2023 · Translational Vision Science & Technology
  92. Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model
    Di Ma, Shengyuan Tian, Qingqing Qin, Yonghui Yu, Jun Jiao, Xiaolu Xiong, Yan Guo, Xingxiao Zhang, Xuan Ouyang · 2023 · Vaccine
  93. Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion
    Yijing Xin, Shubing Chen, Ke Tang, You Wu, Ying Guo · 2022 · International Journal of Molecular Sciences
  94. Breadth of Fc-Mediated Effector Function Delineates Grades of Clinical Immunity Following Human Malaria Challenge
    Irene N. Nkumama, Dennis Odera, Fauzia K. Musasia, Kennedy Mwai, Lydia Nyamako, Linda Murungi, James Tuju, Kristin Fürle, Micha Rosenkranz, Rinter Kimathi et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle
    Kali F. Crofts, Beth C. Holbrook, Courtney L Page, Rebecca A. Gillespie, Ralph B. D’Agostino, Maya Sangesland, David A. Ornelles, Masaru Kanekiyo, Martha A. Alexander‐Miller · 2025 · Nature Communications
  96. Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes
    Bo Ryoung Park, Subbiah Jeeva, Ki‐Hye Kim, Young‐Man Kwon, Judy Oh, Min Chul Kim, Chong Hyun Shin, Baik Lin Seong, Sang‐Moo Kang · 2021 · Virology
  97. Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy – a balancing act
    Hillary A. Vanderven, Stephen John Kent · 2023 · Frontiers in Immunology
  98. Site-Specific Glycosylation Analysis of Murine and Human Fcγ Receptors Reveals High Heterogeneity at Conserved N-Glycosylation Site
    Carlos Humberto Paván, Zaraah Abdoollah, Daniel E. Marrero Roche, Holly Ryan, Erika Moore, Kevin Brown Chandler · 2024 · Journal of Proteome Research
  99. Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope
    Michael Bick, Eduard Puig, David Beauparlant, Rebecca Nedellec, Iszac Burton, Keihvan Ardaghi, Thea R. Zalunardo, Raiza B. Bastidas, Xuduo Li, Javier Guenaga et al. · 2025 · Cell Reports
  100. Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response
    Rory D. de Vries, Nella J. Nieuwkoop, Florian Krammer, Branda T. Hu, Guus F. Rimmelzwaan · 2019 · Virus Research